Characterization of two linear epitopes SARS CoV-2 spike protein formulated in tandem repeat. Tarigan S, Dharmayanti NLPI, Sugiartanti D, Putri R, et al. PLoS One 2023;18:e0280627.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tarigan S, Dharmayanti NLPI, Sugiartanti D, Putri R, et al. Characterization of two linear epitopes SARS CoV-2 spike protein formulated in tandem repeat. PLoS One 2023;18:e0280627.
PMID: 36662754